Search Results - "THAMES, Howard D"

Influence of Technologic Advances on Outcomes in Patients With Unresectable, Locally Advanced Non–Small-Cell Lung Cancer Receiving Concomitant Chemoradiotherapy by Liao, Zhongxing X., M.D, Komaki, Ritsuko R., M.D, Thames, Howard D., Ph.D, Liu, Helen H., Ph.D, Tucker, Susan L., Ph.D, Mohan, Radhe, Ph.D, Martel, Mary K., Ph.D, Wei, Xiong, M.D, Yang, Kunyu, M.D, Kim, Edward S., M.D, Blumenschein, George, M.D, Hong, Waun Ki, M.D, Cox, James D., M.D

“…Purpose In 2004, our institution began using four-dimensional computed tomography (4DCT) simulation and then intensity-modulated radiotherapy (IMRT)…”
Get full text

The Limitations of Model-Based Experimental Design and Parameter Estimation in Sloppy Systems by White, Andrew, Tolman, Malachi, Thames, Howard D, Withers, Hubert Rodney, Mason, Kathy A, Transtrum, Mark K

“…We explore the relationship among experimental design, parameter estimation, and systematic error in sloppy models. We show that the approximate nature of…”
Get full text

HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG) by Lohaus, Fabian, Linge, Annett, Tinhofer, Inge, Budach, Volker, Gkika, Eleni, Stuschke, Martin, Balermpas, Panagiotis, Rödel, Claus, Avlar, Melanie, Grosu, Anca-Ligia, Abdollahi, Amir, Debus, Jürgen, Bayer, Christine, Belka, Claus, Pigorsch, Steffi, Combs, Stephanie E, Mönnich, David, Zips, Daniel, von Neubeck, Cläre, Baretton, Gustavo B, Löck, Steffen, Thames, Howard D, Krause, Mechthild, Baumann, Michael

“…Abstract Objective To investigate the impact of HPV status in patients with locally advanced head and neck squamous cell carcinoma (HNSCC), who received…”
Get full text

p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade by Molkentine, David P, Molkentine, Jessica M, Bridges, Kathleen A, Valdecanas, David R, Dhawan, Annika, Bahri, Reshub, Hefner, Andrew J, Kumar, Manish, Yang, Liangpeng, Abdelhakiem, Mohamed, Pifer, Phillip M, Sandulache, Vlad, Sheth, Aakash, Beadle, Beth M, Thames, Howard D, Mason, Kathryn A, Pickering, Curtis R, Meyn, Raymond E, Skinner, Heath D

“…Squamous cell carcinoma driven by human papillomavirus (HPV) is more sensitive to DNA-damaging therapies than its HPV-negative counterpart. Here, we show that…”
Get full text

Estimation of α/β for Late Rectal Toxicity Based on RTOG 94-06 by Tucker, Susan L., Ph.D, Thames, Howard D., Ph.D, Michalski, Jeff M., M.D, Bosch, Walter R., D.Sc, Mohan, Radhe, Ph.D, Winter, Kathryn, M.S, Cox, James D., M.D, Purdy, James A., Ph.D, Dong, Lei, Ph.D

“…Purpose To estimate α/β, the parameter ratio from the linear-quadratic (LQ) model, for Grade ≥2 late rectal toxicity among patients treated on Radiation…”
Get full text

Ultraviolet A does not induce melanomas in a Xiphophorus hybrid fish model by Mitchell, David L, Fernandez, André A, Nairn, Rodney S, Garcia, Rachel, Paniker, Lakshmi, Trono, David, Thames, Howard D, Gimenez-Conti, Irma

“…We examined the wavelength dependence of ultraviolet (UV) ra-diation (UVR)-induced melanoma in a Xiphophorus backcross hybrid model previously reported to be…”
Get full text

Computational Modeling of Micrometastatic Breast Cancer Radiation Dose Response by Smith, Daniel L., PhD, Debeb, Bisrat G., PhD, Thames, Howard D., PhD, Woodward, Wendy A., MD, PhD

“…Purpose Prophylactic cranial irradiation (PCI) involves giving radiation to the entire brain with the goals of reducing the incidence of brain metastasis and…”
Get full text

Rod Withers' Data are Available Online by Thames, Howard D., PhD, Hunter, Nancy R., BA, Mason, Kathy A., MA

Get full text

Late Rectal Toxicity on RTOG 94-06: Analysis Using a Mixture Lyman Model by Tucker, Susan L., Ph.D, Dong, Lei, Ph.D, Bosch, Walter R., D.Sc, Michalski, Jeff, M.D, Winter, Kathryn, M.S, Mohan, Radhe, Ph.D, Purdy, James A., Ph.D, Kuban, Deborah, M.D, Lee, Andrew K., M.D, Cheung, M. Rex, M.D., Ph.D, Thames, Howard D., Ph.D, Cox, James D., M.D

“…Purpose To estimate the parameters of the Lyman normal-tissue complication probability model using censored time-to-event data for Grade ≥2 late rectal…”
Get full text

Final Report of Radiation Therapy Oncology Group Protocol 9003: Provocative, but Limited Conclusions From Exploratory Analyses by Rosenthal, David I., MD, FACR, Fuller, Clifton D., MD, PhD, Peters, Lester J., MD, FASTRO, Thames, Howard D., PhD

Get full text

Mitigation and Treatment of Radiation-Induced Thoracic Injury With a Cyclooxygenase-2 Inhibitor, Celecoxib by Hunter, Nancy R., MS, Valdecanas, David, BS, Liao, Zhongxing, MD, Milas, Luka, MD, Thames, Howard D., PhD, Mason, Kathy A., MS

“…Purpose To test whether a cyclooxygenase-2 inhibitor (celecoxib) could reduce mortality resulting from radiation-induced pneumonitis. Methods and Materials…”
Get full text

PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis by Ray, Michael E, Thames, Howard D, Levy, Larry B, Horwitz, Eric M, Kupelian, Patrick A, Martinez, Alvaro A, Michalski, Jeff M, Pisansky, Thomas M, Shipley, William U, Zelefsky, Michael J, Zietman, Anthony L, Kuban, Deborah A

“…To determine the significance of prostate-specific antigen (PSA) nadir (nPSA) and the time to nPSA (T(nPSA)) in predicting biochemical or clinical disease-free…”
Get more information

Breast Conservation After Neoadjuvant Chemotherapy: The M.D. Anderson Cancer Center Experience by CHEN, Allen M, MERIC-BERNSTAM, Funda, SINGLETARY, S. Eva, AMES, Fredrick C, FEIG, Barry W, SAHIN, Aysegul A, PERKINS, George H, SCHECHTER, Naomi R, HORTOBAGYI, Gabriel N, BUCHHOLZ, Thomas A, HUNT, Kelly K, THAMES, Howard D, OSWALD, Mary Jane, OUTLAW, Elesyia D, STROM, Eric A, MCNEESE, Marsha D, KUERER, Henry M, ROSS, Merrick I

“…To determine patterns of local-regional recurrence (LRR) and ipsilateral breast tumor recurrence (IBTR) among patients treated with breast conservation therapy…”
Get full text

Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer center by Sosa, Alan J., Rooney, Michael K., Thames, Howard D., Sanders, Jeremiah W., Swanson, David M., Choi, Seungtaek L., Nguyen, Quynh-Nhu, Mok, Henry, Kuban, Deborah A., Ron Zhu, X., Shah, Shalin, Mayo, Lauren L., Hoffman, Karen E., Tang, Chad, McGuire, Sean E., Sahoo, Narayan, Zhang, Xiaodong, Lee, Andrew K., Pugh, Thomas J., Mahmood, Usama, Davis, John W., Chapin, Brian F., Corn, Paul, Kudchadker, Reena, Ausat, Noveen, Frank, Steven J.

“…•Proton therapy is associated with low rates of late high grade genitourinary and gastrointensity toxicity for the treatment of localized prostate cancer.•Only…”
Get full text

Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy by Krause, Mechthild, Zips, Daniel, Thames, Howard D., Kummermehr, Johann, Baumann, Michael

“…The combination of molecular-targeted agents with irradiation is a highly promising avenue for cancer research and patient care. Molecular-targeted agents are…”
Get full text

Comparison of Treatment Tolerance and Outcomes in Patients With Cervical Cancer Treated With Concurrent Chemoradiotherapy in a Prospective Randomized Trial or With Standard Treatment by Torres, Mylin A., M.D, Jhingran, Anuja, M.D, Thames, Howard D., Ph.D, Levenback, Charles F., M.D, Bodurka, Diane C., M.D, Ramondetta, Lois M., M.D, Eifel, Patricia J., M.D

“…Purpose To compare the treatment and outcomes of cervical cancer patients treated with concurrent chemoradiotherapy (CT-RT) in a multi-institutional trial or…”
Get full text

The Ratio of Positive to Excised Nodes Identifies High-risk Subsets and Reduces Inter-Institutional Differences in Locoregional Recurrence Risk Estimates in Breast Cancer Patients With 1–3 Positive Nodes: An Analysis of Prospective Data From British Columbia and the M. D. Anderson Cancer Center by Truong, Pauline T., M.D., C.M, Woodward, Wendy A., M.D., Ph.D, Thames, Howard D., Ph.D, Ragaz, Joseph, M.D, Olivotto, Ivo A., M.D, Buchholz, Thomas A., M.D

“…Purpose To examine the power of the nodal ratio (NR) of positive/excised nodes in predicting postmastectomy locoregional recurrence (LRR) in patients with 1–3…”
Get full text

The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis by Wang, Aijin, Arantes, Stacey, Yan, Leqin, Kiguchi, Kaoru, McArthur, Mark J, Sahin, Aysegul, Thames, Howard D, Aldaz, C Marcelo, Macleod, Michael C

“…Overexpression of the bZip transcription factor, ATF3, in basal epithelial cells of transgenic mice under the control of the bovine cytokeratin-5 (CK5)…”
Get full text

Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy by Tucker, Susan L, Dong, Lei, Cheung, Rex, Johnson, Jennifer, Mohan, Radhe, Huang, Eugene H, Liu, H Helen, Thames, Howard D, Kuban, Deborah

“…To compare the fits of normal-tissue complication probability (NTCP) models based on rectal dose-wall histograms (DWHs) vs. dose-volume histograms (DVHs) when…”
Get more information

Decreased repopulation as well as increased reoxygenation contribute to the improvement in local control after targeting of the EGFR by C225 during fractionated irradiation by Krause, Mechthild, Ostermann, Gernot, Petersen, Cordula, Yaromina, Ala, Hessel, Franziska, Harstrick, Andreas, van der Kogel, Albert J, Thames, Howard D, Baumann, Michael

“…Inhibition of repopulation and enhanced reoxygenation has been suggested to contribute to improvement of local tumour control after fractionated irradiation…”
Get full text